Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Oxybutynin hydrochloride 2.5 mg oral tablet |
Is a |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 5 mg oral tablet |
Is a |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 3 mg oral tablet |
Is a |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 2.5mg/5mL elixir |
Is a |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 5mg/5mL s/f oral solution |
Is a |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 15mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin chloride 5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin chloride 5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 5mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride m/r product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 15mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 2.5mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 100 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 3 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely oxybutynin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely oxybutynin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely oxybutynin hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely oxybutynin hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 3 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely oxybutynin hydrochloride 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely oxybutynin hydrochloride 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 100 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |
Oxybutynin hydrochloride 100 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxybutynin hydrochloride |
Inferred relationship |
Some |
1 |